ESR1 and breast cancer: Likewise, at the transcriptional level, GCs inhibit ERα transcriptional activity and E2-mediated cell proliferation in ERα+ BC (Karmakar et al, 2013; West et al, 2016; Yang et al, 2017), but drive the expression of pro-tumorigenic genes in TNBC (Chen et al, 2015).